{"groups":[{"description":"Velcade (Bortezomib)\n\nThalidomide\n\nDexamethasone\n\nAllocated to treatment (n=135) Received allocated treatment (n=135)","id":"FG000","title":"Thal + Dex + Velcade"},{"description":"Standard treatment\n\nThalidomide\n\nDexamethasone\n\nAllocated to treatment (n=134) Received allocated treatment (n=134)","id":"FG001","title":"Thal + Dex"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"135"},{"groupId":"FG001","numSubjects":"134"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"52"},{"groupId":"FG001","numSubjects":"54"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"83"},{"groupId":"FG001","numSubjects":"80"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"FPI 08-Jul-2005 LPI 21-Jun-2010"}